LAMC2 As a Prognostic Biomarker in Human Cancer: a Systematic Review and Meta-analysis

Overview

Journal BMJ Open

Specialty General Medicine

Date 2022 Nov 17

PMID 36396303

Authors

Tao Fu

Jun-Xia Liu

Juan Xie

Zhen Gao

Zhenshan Yang

Affiliations

Soon will be listed here.

Abstract

Objectives: Accumulating evidence suggested that the laminin γ2 (LAMC2) expression level was upregulated in various cancers. However, the potential prognostic value of LAMC2 in cancers remains unclear. We conducted a meta-analysis to clarify the association of LAMC2 expression with prognosis.

Design: We searched Embase, Web of Science and PubMed (up to 25 November 2021) to collect all eligible studies, and meta-analysis was performed to interpret the association of LAMC2 expression with clinicopathological parameters, overall survival (OS), disease-specific survival (DSS) and progression-free survival (PFS).

Eligibility Criteria For Including Studies: We included studies that investigate the relationship between LAMC2 and prognosis of cancers, patients were divided into two groups, and associations of LAMC2 expression with clinicopathological features were described.

Results: Seven studies were finally included. We found that increased LAMC2 expression was significantly associated with lymph node metastasis (log OR 0.88, 95% CI 0.38 to 1.38, p<0.001), tumour-node-metastasis stages (log OR: 0.95, 95% CI 0.39 to 1.50, p<0.001) and tumour status (log OR 1.26, 95% CI 0.84 to 1.68, p<0.001), but not with age (log OR -0.05, 95% CI -0.37 to 0.27, p=0.75) or gender (log OR -0.07, 95% CI -0.52 to 0.38, p=0.75). In addition, higher LAMC2 expression was found to be significantly associated with OS/PFS/DSS (HR 1.85, 95% CI 1.31 to 2.40, p<0.001). A similar result was found in The Cancer Genome Atlas database. High LAMC2 expression was significantly associated with OS in lung adenocarcinoma, mesothelioma, skin cutaneous melanoma, neck squamous cell carcinoma and brain lower grade glioma.

Conclusion: Our results suggested that higher LAMC2 expression was correlated with worse survival, lymph node metastasis, tumour-node-metastasis stages and tumour status. This study was subject to inherent limitations, but the results presented here provide insights regarding the potential use of LAMC2 as a biomarker for human cancer.

Study Registration: researchregistry.com (researchregistry1319).

Citing Articles

Exploring RNA cargo in extracellular vesicles for pleural mesothelioma detection.

Kraft A, Kirschner M, Orlowski V, Ronner M, Bodmer C, Boeva V BMC Cancer. 2025; 25(1):212.

PMID: 39920655 PMC: 11804012. DOI: 10.1186/s12885-025-13617-y.

Elevated Expression of Cell Adhesion, Metabolic, and Mucus Secretion Gene Clusters Associated with Tumorigenesis, Metastasis, and Poor Survival in Pancreatic Ductal Adenocarcinoma.

Balakrishnan K, Xiao Y, Chen Y, Dong J Cancers (Basel). 2024; 16(23).

PMID: 39682235 PMC: 11640259. DOI: 10.3390/cancers16234049.

Identification of new subtypes of breast cancer based on vasculogenic mimicry related genes and a new model for predicting the prognosis of breast cancer.

Liang X, Ma X, Luan F, Gong J, Zhao S, Pan Y Heliyon. 2024; 10(17):e36565.

PMID: 39263085 PMC: 11387377. DOI: 10.1016/j.heliyon.2024.e36565.

TNF Induces Laminin-332-Encoding Genes in Endothelial Cells and Laminin-332 Promotes an Atherogenic Endothelial Phenotype.

Hayderi A, Zegeye M, Meydan S, Sirsjo A, Kumawat A, Ljungberg L Int J Mol Sci. 2024; 25(16).

PMID: 39201392 PMC: 11354388. DOI: 10.3390/ijms25168699.

LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway.

Cheng L, Li X, Dong W, Yang J, Li P, Qiang X J Cancer Res Clin Oncol. 2024; 150(5):230.

PMID: 38703300 PMC: 11069487. DOI: 10.1007/s00432-024-05720-7.

References

You G, Cheng A, Lee L, Huang Y, Liu H, Chen Y . Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses. BMC Cancer. 2019; 19(1):64. PMC: 6332600. DOI: 10.1186/s12885-018-5243-3. View

Givant-Horwitz V, Davidson B, Reich R . Laminin-induced signaling in tumor cells. Cancer Lett. 2005; 223(1):1-10. DOI: 10.1016/j.canlet.2004.08.030. View

Daisuke H, Kato H, Fukumura K, Mayeda A, Miyagi Y, Seiki M . Novel LAMC2 fusion protein has tumor-promoting properties in ovarian carcinoma. Cancer Sci. 2021; 112(12):4957-4967. PMC: 8645749. DOI: 10.1111/cas.15149. View

Wang S, Zhang L, Shi P, Zhang Y, Zhou H, Cao X . Genome-wide profiles of metastasis-associated mRNAs and microRNAs in salivary adenoid cystic carcinoma. Biochem Biophys Res Commun. 2018; 500(3):632-638. DOI: 10.1016/j.bbrc.2018.04.122. View

Yang C, Liu Z, Zeng X, Wu Q, Liao X, Wang X . Evaluation of the diagnostic ability of laminin gene family for pancreatic ductal adenocarcinoma. Aging (Albany NY). 2019; 11(11):3679-3703. PMC: 6594799. DOI: 10.18632/aging.102007. View

Diao B, Yang P . Comprehensive Analysis of the Expression and Prognosis for Laminin Genes in Ovarian Cancer. Pathol Oncol Res. 2021; 27:1609855. PMC: 8423899. DOI: 10.3389/pore.2021.1609855. View

Jin G, Ruan Q, Shangguan F, Lan L . RUNX2 and LAMC2: promising pancreatic cancer biomarkers identified by an integrative data mining of pancreatic adenocarcinoma tissues. Aging (Albany NY). 2021; 13(19):22963-22984. PMC: 8544338. DOI: 10.18632/aging.203589. View

Thangaraj S, Shyamsundar V, Krishnamurthy A, Ramshankar V . Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in Oral Tongue squamous cell carcinoma. Sci Rep. 2021; 11(1):250. PMC: 7794513. DOI: 10.1038/s41598-020-78624-4. View

Garg M, Braunstein G, Koeffler H . LAMC2 as a therapeutic target for cancers. Expert Opin Ther Targets. 2014; 18(9):979-82. DOI: 10.1517/14728222.2014.934814. View

10.

Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang K . LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death Differ. 2018; 25(11):1980-1995. PMC: 6219493. DOI: 10.1038/s41418-018-0084-9. View

11.

Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z . GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45(W1):W98-W102. PMC: 5570223. DOI: 10.1093/nar/gkx247. View

12.

Hohenester E . Structural biology of laminins. Essays Biochem. 2019; 63(3):285-295. PMC: 6744579. DOI: 10.1042/EBC20180075. View

13.

Kirtonia A, Pandey A, Ramachandran B, Mishra D, Dawson D, Sethi G . Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade. Cell Mol Life Sci. 2022; 79(7):362. PMC: 11073089. DOI: 10.1007/s00018-022-04392-1. View

14.

Kashima H, Wu R, Wang Y, Sinno A, Miyamoto T, Shiozawa T . Laminin C1 expression by uterine carcinoma cells is associated with tumor progression. Gynecol Oncol. 2015; 139(2):338-44. PMC: 4862403. DOI: 10.1016/j.ygyno.2015.08.025. View

15.

Stang A . Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25(9):603-5. DOI: 10.1007/s10654-010-9491-z. View

16.

Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021; 372:n71. PMC: 8005924. DOI: 10.1136/bmj.n71. View

17.

Ran T, Chen Z, Zhao L, Ran W, Fan J, Hong S . LAMB1 Is Related to the T Stage and Indicates Poor Prognosis in Gastric Cancer. Technol Cancer Res Treat. 2021; 20:15330338211004944. PMC: 8020091. DOI: 10.1177/15330338211004944. View

18.

Islam S, Kitagawa T, Baron B, Abiko Y, Chiba I, Kuramitsu Y . ITGA2, LAMB3, and LAMC2 may be the potential therapeutic targets in pancreatic ductal adenocarcinoma: an integrated bioinformatics analysis. Sci Rep. 2021; 11(1):10563. PMC: 8131351. DOI: 10.1038/s41598-021-90077-x. View

19.

Tierney J, Stewart L, Ghersi D, Burdett S, Sydes M . Practical methods for incorporating summary time-to-event data into meta-analysis. Trials. 2007; 8:16. PMC: 1920534. DOI: 10.1186/1745-6215-8-16. View

20.

Garg M, Kanojia D, Okamoto R, Jain S, Madan V, Chien W . Laminin-5γ-2 (LAMC2) is highly expressed in anaplastic thyroid carcinoma and is associated with tumor progression, migration, and invasion by modulating signaling of EGFR. J Clin Endocrinol Metab. 2013; 99(1):E62-72. PMC: 3879679. DOI: 10.1210/jc.2013-2994. View